Valerie Daggett
Valerie Daggett is the Founder and CEO of AltPep Corporation and a Professor at the University of Washington. She founded AltPep Corporation, which is still running.
Pictory Wins Startup of the Year at 2024 GeekWire Awards in Seattle Featuring Live Music and Surprise Guests
The 2024 GeekWire Awards in Seattle celebrated Pacific Northwest tech with winners like Pictory, live music, and surprise guests, hosted at Showbox SoDo. The event featured sponsors such as Astound Business Solutions and included networking, entertainment, and a nostalgic tech theme.
AltPep Raises $52.9M to Advance Early Detection and Treatments for Alzheimer’s and Parkinson’s Diseases
AltPep, a University of Washington spinout developing tests and treatments for Alzheimer’s and Parkinson’s, raised $52.9 million in Series B funding to advance clinical trials and regulatory approval for its early detection blood test. The company targets toxic oligomers linked to Alzheimer’s and a related protein in Parkinson’s, aiming to enable early screening and preventive treatment.
UW spinout AltPep raises $44.4M as its Alzheimer’s blood test earns FDA breakthrough designation
University of Washington spinout AltPep raised $44.4 million and is developing experimental blood tests to detect Alzheimer’s and Parkinson’s diseases early, plus treatments; its Alzheimer’s test received FDA breakthrough device designation. The three-year-old Seattle startup has 25 employees, raised $23.1M in a 2021 Series A, is hiring, and is pursuing partnerships and clinical-ready development.
AltPep, UW spinout led by Valerie Daggett, raises $23.1M Series A to develop early-detection and therapeutics for Alzheimer’s
Seattle biotech AltPep, spun out of the University of Washington in 2019 and led by founder/CEO Valerie Daggett, raised $23.1 million in a Series A to develop detection tools and preclinical therapies for Alzheimer’s and other amyloid protein diseases. The company’s technology, based on UW-licensed research into alpha-sheet protein structures, will support early detection efforts and expansion into a new 7,500 sq ft Seattle lab.
Organizations
-
AltPep Executive Officer, Director, Promoter 2019–present, Founder and CEO 2019–present · current
-
University of Washington Professor 1993–present · current
Education
-
Stanford University Structural Biology · 1990–1993
-
University of California, San Francisco Doctor of Philosophy (Ph.D.), Pharmaceutical Chemistry · 1985–1990
-
Reed College Bachelor’s Degree, Chemistry · 1979–1983
